Natera Announces Fourth Quarter and Fiscal 2022 Earnings Conference Call

Rhea-AI Summary

Natera, Inc. (NASDAQ: NTRA) will announce its fourth quarter and year-end results for 2022 on February 28, 2023, after market close. The company will host a conference call and webcast at 1:30 p.m. PT (4:30 p.m. ET) to discuss its financial performance. Investors can access the conference through a live dial-in number or a webcast link. Natera specializes in cell-free DNA testing in fields like oncology and women's health, with a mission to enhance personalized genetic testing as a standard healthcare practice.

Positive

• Natera is a leader in cell-free DNA testing, which is growing in importance in personalized healthcare.
• The company has over 100 peer-reviewed publications validating the accuracy of its tests.

Negative

• None.

AUSTIN, Texas--(BUSINESS WIRE)-- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced that it will release results for its fourth quarter and year ended December 31, 2022, after the market close on Feb. 28, 2023. Natera will host a conference call and webcast shortly thereafter at 1:30 p.m. PT (4:30 p.m. ET).

Earnings Conference Call Information:

Event:		Natera’s Fourth Quarter and Year-End 2022 Financial Results
Date:		Tuesday, Feb. 28, 2023
Time:		1:30 p.m. PT (4:30 p.m. ET)
Live Dial-In:		1 (888) 770-7321, Domestic
		1 (929) 201-7107, International
Conference ID:		7684785
Webcast:		https://events.q4inc.com/attendee/196748198

A webcast replay will be available at investor.natera.com.

About Natera

Natera™ is a global leader in cell-free DNA testing, dedicated to oncology, women’s health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard of care to protect health, and inform earlier, more targeted interventions that help lead to longer, healthier lives. Natera’s tests are validated by more than 100 peer-reviewed publications that demonstrate high accuracy. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas and San Carlos, California. For more information, visit www.natera.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230221005398/en/

Investor Relations: Mike Brophy, CFO, Natera, Inc., 510-405-4709, investor@natera.com

Media: Lesley Bogdanow, VP of Corporate Communications, Natera, Inc., pr@natera.com

Source: Natera, Inc.

FAQ

When will Natera release its fourth quarter and year-end 2022 financial results?

Natera will release its financial results on February 28, 2023, after market close.

What time is Natera's earnings conference call on February 28, 2023?

The earnings conference call will be held at 1:30 p.m. PT (4:30 p.m. ET) on February 28, 2023.

How can I listen to Natera's earnings call?

You can listen to the call via a live dial-in number or through a webcast available on Natera's investor relations website.

What is Natera's focus area in the medical field?

Natera focuses on cell-free DNA testing for oncology, women's health, and organ health.